SGMT Sagimet Biosciences Inc. - Series A Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$9.14
· of 52w range
· above low
· to high
$4.5052w low
$11.4552w high
P/E
-3.7
EPS
$-1.58
Revenue
$2M
your badges
52W Range
$4–$11
Analyst Rating
BUY
Price Target
$28
P/E
-3.7
ROE
-42.3%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
SGMT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$9.14
P/E
-3.7
EPS
$-1.58
Revenue
$2M
ROE
-42.3%
52W Range
$5–$11
SGMT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$2M2023-12-31 → 2023-12-31
EPS$-1.582022-12-31 → 2025-12-31
Net margin·2023-12-31 → 2023-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | SGMT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -3.75Y avg ≈-3.0 | ≈-3.0 | · | · | |
| Price / Tangible Book | 0.0 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | SGMT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -36.9%5Y avg ≈-38.4% | ≈-38.4% | -40.8% | In line | |
| ROE | -42.3%5Y avg ≈-33.2% | ≈-33.2% | -52.8% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | SGMT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 45.05Y avg ≈24.7 | ≈24.7 | 16.7 | Strong liquidity | |
| Quick Ratio | 22.25Y avg ≈24.3 | ≈24.3 | 9.3 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | SGMT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$125.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
15.7%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 19, 2026 | $-0.26 | $-0.25 | -3.5% |
| March 31, 2026 | May 20, 2026 | $-0.33 | $-0.38 | 13.6% |
| Dec. 31, 2025 | $-0.29 | $-0.41 | 30.1% | |
| Sept. 30, 2025 | $-0.40 | $-0.39 | -1.7% | |
| June 30, 2025 | $-0.32 | $-0.52 | 38.2% | |
| March 31, 2025 | $-0.56 | $-0.68 | 17.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | · | · | $2M | |
| R&D Expense | $39M | $38M | $20M | |
| SG&A Expense | $18M | $16M | $13M | |
| Operating Expenses | $57M | $54M | $33M | |
| Operating Income | $-57M | $-54M | $-31M | |
| Other Non-op | $6M | $9M | $3M | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-51M | $-46M | $-28M | |
| EPS (Basic) | $-1.58 | $-1.45 | $-2.66 | |
| EPS (Diluted) | $-1.58 | $-1.45 | $-2.66 | |
| Shares (Basic) | 32,345,525 | 31,350,725 | 10,460,335 | |
| Shares (Diluted) | 32,345,525 | 31,350,725 | 10,460,335 | |
| EBITDA | $-57M | $-54M | $-31M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $35M | $76M | $75M | |
| Short-term Investments | $78M | $75M | $20M | |
| Prepaid Expense | $3M | $2M | $2M | |
| Other Current Assets | $199.0K | $157.0K | $74.0K | |
| Current Assets | $116M | $153M | $97M | |
| Other Non-current Assets | $0 | · | · | |
| Total Assets | $116M | $160M | $97M | |
| Accounts Payable | $1M | $1M | $186.0K | |
| Accrued Liabilities | $4M | $3M | $5M | |
| Current Liabilities | $5M | $4M | $6M | |
| Capital Leases | $0 | · | · | |
| Total Liabilities | $5M | $4M | $6M | |
| Paid-in Capital | $458M | $451M | $341M | |
| Retained Earnings | $-346M | $-295M | $-250M | |
| AOCI | $120.0K | $230.0K | $30.0K | |
| Stockholders' Equity | $111M | $156M | $91M | |
| Liabilities + Equity | $116M | $160M | $97M | |
| Shares Outstanding | · | · | 0 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $5M | |
| Operating Cash Flow | $-46M | $-42M | $-24M | |
| Investing Cash Flow | $5M | $-62M | $13M | |
| Stock Issued | $0 | $106M | · | |
| Net Stock Activity | $0 | $106M | · | |
| Financing Cash Flow | $275.0K | $105M | $86M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | · | -1537.0% | |
| Net Margin | · | · | -1393.8% | |
| EBITDA Margin | · | · | -1537.0% | |
| ROA | -36.9% | -35.5% | -43.0% | |
| ROE | -42.3% | -27.9% | -29.5% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 22.8 | 34.3 | 17.1 | |
| Quick Ratio | 22.2 | 34.0 | 16.8 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue / Share | · | · | $0.19 | |
| Cash Flow / Share | $-1.41 | $-1.35 | $-2.27 | |
| EPS (TTM) | $-1.58 | $-1.45 | $-2.66 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | · | · | $2M | |
| Net Income TTM | $-51M | $-46M | $-28M | |
| Market Cap | · | · | $0 | |
| P/E | -3.7 | -3.1 | -2.0 | |
| P/S | · | · | 0.0 | |
| P / Tangible Book | · | · | 0.0 | |
| P / Cash Flow | · | · | 0.0 | |
| Earnings Yield | -26.7% | -32.2% | -49.1% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | $0 | $2M | |
| R&D Expense | $12M | $7M | $7M | $10M | $7M | $15M | $14M | $13M | $6M | $5M | $6M | $5M | |
| SG&A Expense | $4M | $5M | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $16M | $12M | $11M | $14M | $12M | $20M | $18M | $17M | $11M | $9M | $9M | $9M | |
| Operating Income | $-16M | $-12M | $-11M | $-14M | $-12M | $-20M | $-18M | $-17M | $-11M | $-9M | $-9M | $-7M | |
| Other Non-op | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Net Income | $-14M | $-11M | $-10M | $-13M | $-10M | $-18M | $-16M | $-15M | $-8M | $-7M | $-8M | $-6M | |
| EPS (Basic) | $-0.26 | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| EPS (Diluted) | $-0.26 | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| Shares (Basic) | 53,114,533 | 32,559,704 | · | 32,464,893 | 32,195,366 | 32,195,345 | · | 32,143,336 | 31,913,887 | 29,039,427 | · | 18,194,682 | |
| Shares (Diluted) | 53,114,533 | 32,559,704 | · | 32,464,893 | 32,195,366 | 32,195,345 | · | 32,143,336 | 31,913,887 | 29,039,427 | · | 18,194,682 | |
| EBITDA | $-16M | $-12M | · | $-14M | $-12M | $-20M | · | $-17M | $-11M | $-9M | · | $-7M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $37M | $35M | $32M | $42M | $65M | $76M | $77M | $96M | $177M | $75M | $102M | |
| Short-term Investments | $74M | $68M | $78M | $84M | $83M | $80M | $75M | $75M | $70M | $17M | $20M | $0 | |
| Prepaid Expense | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $5M | $378.0K | $786.0K | $2M | $974.0K | |
| Other Current Assets | $226.0K | $248.0K | $199.0K | $253.0K | $173.0K | $263.0K | $157.0K | $101.0K | $130.0K | $108.0K | $74.0K | $77.0K | |
| Current Assets | $244M | $108M | $116M | $119M | $127M | $146M | $153M | $157M | $167M | $194M | $97M | $103M | |
| Other Non-current Assets | $55.0K | · | · | · | · | $62.0K | · | · | · | · | · | · | |
| Total Assets | $263M | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Accounts Payable | $1M | $2M | $1M | $4M | $2M | $3M | $1M | $1M | $2M | $531.0K | $186.0K | $2M | |
| Accrued Liabilities | $4M | $3M | $4M | $5M | $5M | $4M | $3M | $3M | $4M | $4M | $5M | $3M | |
| Current Liabilities | $5M | $5M | $5M | $9M | $7M | · | $4M | · | · | · | $6M | $5M | |
| Capital Leases | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | · | · | · | · | $7M | · | $4M | $6M | $5M | · | $5M | |
| Paid-in Capital | $627M | $459M | $458M | $456M | $454M | $452M | $451M | $449M | $448M | $446M | $341M | $339M | |
| Retained Earnings | $-371M | $-357M | $-346M | $-337M | $-324M | $-313M | $-295M | $-279M | $-264M | $-256M | $-250M | $-242M | |
| AOCI | $-77.0K | $8.0K | $120.0K | $117.0K | $76.0K | $121.0K | $230.0K | $441.0K | $-23.0K | $7.0K | $30.0K | · | |
| Stockholders' Equity | $256M | $102M | $111M | $119M | $130M | $139M | $156M | $171M | $183M | $190M | $91M | $98M | |
| Liabilities + Equity | $263M | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | 0 | 0 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $759.0K | $1M | $2M | |
| Operating Cash Flow | $-11M | $-9M | $-12M | $-10M | $-9M | $-15M | $-11M | $-20M | $-6M | $-6M | $-7M | $-4M | |
| Investing Cash Flow | $-24M | $10M | $14M | $75.0K | $-13M | $3M | $10M | $624.0K | $-75M | $3M | $-20M | $0 | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $106M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $106M | · | · | |
| Financing Cash Flow | · | · | $0 | $274.0K | · | · | $0 | $0 | $-27.0K | $105M | $0 | $87M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -317.6% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| ROA | -7.0% | -8.4% | · | -8.5% | -6.4% | -10.7% | · | -10.5% | -7.7% | -6.8% | · | -12.3% | |
| ROE | -7.2% | -8.8% | · | -8.9% | -6.6% | -11.1% | · | -10.9% | 107.4% | -7.0% | · | -13.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 45.0 | 20.3 | · | 13.1 | 17.6 | · | · | · | · | · | · | 20.4 | |
| Quick Ratio | 44.3 | 19.7 | · | 12.8 | 17.3 | · | · | · | · | · | · | 20.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-0.26 | · | · | · | $-0.45 | · | · | · | $-0.21 | · | · | |
| EPS (TTM) | $-1.29 | $-1.35 | · | $-1.80 | $-1.85 | $-1.78 | · | $68.14 | $68.24 | $32.69 | · | $-110.80 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-47M | $-44M | · | $-58M | $-59M | $-57M | · | $-38M | $-29M | $-28M | · | $-27M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| P/E | -6.0 | -3.9 | · | -3.8 | -4.1 | -1.8 | · | 0.0 | 0.1 | 0.2 | · | -0.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Earnings Yield | -16.7% | -25.8% | · | -26.2% | -24.3% | -54.6% | · | 2459.9% | 1995.3% | 603.1% | · | -1259.1% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | · | · | $2M | · |
| Operating Margin % | · | · | -1537.0% | · |
| Net Income | $-51M | $-46M | $-28M | $-30M |
| Diluted EPS | $-1.58 | $-1.45 | $-2.66 | $-165.20 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Current Ratio | 22.8 | 34.3 | 17.1 | · |
| Quick Ratio | 22.2 | 34.0 | 16.8 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 133 filers · $406.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
133
Value held
$406.4M
New positions
58
Exited positions
23
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 58 (+40 vs prior Q) | 23 (+12 vs prior Q) | 39 (+4 vs prior Q) | 12 (-8 vs prior Q) | +38.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $50,830,842 | 6,575,788 | 12.51% | Shares |
| Balyasny Asset Management L.P. | $28,029,853 | 3,626,113 | 6.90% | Shares |
| Woodline Partners LP | $23,195,040 | 3,000,652 | 5.71% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $22,631,106 | 2,927,698 | 5.57% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $19,837,283 | 2,566,272 | 4.88% | Shares |
| BVF INC/IL | $19,325,000 | 2,500,000 | 4.75% | Shares |
| Caligan Partners LP | $19,325,000 | 2,500,000 | 4.75% | Shares |
| Affinity Asset Advisors, LLC | $19,308,489 | 2,497,864 | 4.75% | Shares |
| FEDERATED HERMES, INC. | $16,130,307 | 2,086,715 | 3.97% | Shares |
| GREAT POINT PARTNERS LLC | $15,691,382 | 2,029,933 | 3.86% | Shares |
| STATE STREET CORP | $15,422,061 | 1,995,092 | 3.79% | Shares |
| Saturn V Capital Management LP | $11,439,766 | 1,479,918 | 2.81% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $11,165,095 | 1,444,019 | 2.75% | Shares |
| Blue Owl Capital Holdings LP | $9,744,005 | 1,260,544 | 2.40% | Shares |
| VANGUARD GROUP INC | $7,456,536 | 1,259,550 | 1.83% | Shares |
| BAKER BROS. ADVISORS LP | $7,366,659 | 952,996 | 1.81% | Shares |
| MILLENNIUM MANAGEMENT LLC | $7,243,203 | 937,025 | 1.78% | Shares |
| Aberdeen Group plc | $6,552,721 | 847,700 | 1.61% | Shares |
| GOLDMAN SACHS GROUP INC | $5,867,734 | 759,086 | 1.44% | Shares |
| HHLR ADVISORS, LTD. | $5,602,704 | 724,800 | 1.38% | Shares |
| AMERIPRISE FINANCIAL INC | $4,492,807 | 581,217 | 1.11% | Shares |
| Vestal Point Capital, LP | $4,139,044 | 535,452 | 1.02% | Shares |
| NORTHERN TRUST CORP | $3,620,617 | 468,385 | 0.89% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $3,587,454 | 464,095 | 0.88% | Shares |
| ADAR1 Capital Management, LLC | $3,381,875 | 437,500 | 0.83% | Shares |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $3,207,950 | 415,000 | 0.79% | Shares |
| Seven Fleet Capital Management LP | $3,119,403 | 403,545 | 0.77% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3,118,916 | 403,482 | 0.77% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $3,098,478 | 400,838 | 0.76% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $3,076,547 | 397,972 | 0.76% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,681,746 | 346,927 | 0.66% | Shares |
| Atom Investors LP | $2,674,719 | 346,018 | 0.66% | Shares |
| UBS Group AG | $2,627,659 | 339,930 | 0.65% | Shares |
| RAYMOND JAMES FINANCIAL INC | $2,566,538 | 332,023 | 0.63% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,236,289 | 289,300 | 0.55% | Call option |
| Rock Springs Capital Management LP | $1,932,500 | 250,000 | 0.48% | Shares |
| Palo Alto Investors LP | $1,932,500 | 250,000 | 0.48% | Shares |
| BARCLAYS PLC | $1,761,907 | 227,931 | 0.43% | Shares |
| Pale Fire Capital SE | $1,715,094 | 221,875 | 0.42% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1,712,512 | 221,541 | 0.42% | Shares |
| Bank of New York Mellon Corp | $1,551,011 | 200,648 | 0.38% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,440,872 | 186,400 | 0.35% | Put option |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,359,491 | 175,872 | 0.33% | Shares |
| Sofinnova Investments, Inc. | $1,288,336 | 166,667 | 0.32% | Shares |
| Driehaus Capital Management LLC | $1,288,336 | 166,667 | 0.32% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,110,677 | 143,684 | 0.27% | Shares |
| Nuveen, LLC | $1,087,124 | 140,637 | 0.27% | Shares |
| CITADEL ADVISORS LLC | $1,035,047 | 133,900 | 0.25% | Put option |
| Propel Bio Management, LLC | $973,037 | 125,878 | 0.24% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $927,878 | 120,036 | 0.23% | Shares |
Company insiders 21 insiders · 7 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| David Happel | President & CEO | July 20, 2026 S | 741,570 | 0 | 2 | $-561,897 |
| Thierry Chauche | Chief Financial Officer | May 28, 2026 A | 59,688 | 0 | 1 | $-7,032 |
| Dennis Hom | Chief Financial Officer | July 18, 2023 A | · | 0 | 0 | $0 |
| Anthony M Rimac | Chief Operating Officer | July 18, 2023 A | · | 0 | 0 | $0 |
| Elizabeth Rozek | Chief Legal & Admin. Officer | July 20, 2026 S | 224,414 | 0 | 2 | $-95,883 |
| Andreas Grauer | Chief Medical Officer | May 28, 2026 A | · | 0 | 0 | $0 |
| Eduardo Bruno Martins | Chief Medical Officer | Feb. 19, 2026 A | 147,296 | 0 | 1 | $-19,510 |
| Jennifer Jarrett | Director | June 12, 2026 A | · | 0 | 0 | $0 |
| Anne M. Phillips | Director | June 12, 2026 A | · | 0 | 0 | $0 |
| Paul W. Hoelscher | Director | June 12, 2026 A | · | 0 | 0 | $0 |
| Elizabeth A Grammer | Director | June 12, 2026 A | · | 0 | 0 | $0 |
| Beth C Seidenberg | Director | June 12, 2026 A | 46,875 | 0 | 0 | $0 |
| Timothy P Walbert | Director | June 9, 2025 A | · | 0 | 0 | $0 |
| Merdad Parsey | Director | June 5, 2024 A | 12,794 | 0 | 0 | $0 |
| Jinzi Jason Wu | Director | July 18, 2023 A | 1,654,701 | 0 | 0 | $0 |
| Richard J Rodgers | Director | July 18, 2023 A | · | 0 | 0 | $0 |
| New Enterprise Associates 13, L.P. | 10% owner | Jan. 29, 2024 J | 3,000,275 | 0 | 0 | $0 |
| Forest Baskett | 10% owner | Jan. 29, 2024 J | 11,300 | 0 | 0 | $0 |
| Scott D. Sandell | 10% owner | Jan. 29, 2024 J | 6,997 | 0 | 0 | $0 |
| Patrick J. Kerins | 10% owner | Jan. 29, 2024 J | 13,139 | 0 | 0 | $0 |
| George Kemble | · | Aug. 14, 2026 M | 62,161 | 0 | 4 | $-4,222,044 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 23 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.32% | 139,371 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.15% | 199,699 SH | Sept. 11, 2026 | Daily |
| IBB · iShares Trust | 0.05% | 450,509 SH | Sept. 11, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.05% | 33,403 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.04% | 4,372 SH | Oct. 2, 2026 | Daily |
| IWO · iShares Trust | 0.03% | 431,516 SH | Sept. 11, 2026 | Daily |
| IWM · iShares Trust | 0.02% | 1,492,966 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 49,546 SH | Aug. 19, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.01% | 456 NS | July 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.01% | 27,951 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 658,772 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 337,803 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 11,145 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 136,754 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2,377 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 25,198 SH | Sept. 10, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.00% | 2,817 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3,445 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 1,776 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 8,721 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,861,227 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4,988 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 118,005 SH | Sept. 11, 2026 | Daily |
SGMT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 18 analysts
BUY
Median target
$28.00
+206.3%
6 33.3%
Strong Buy
10 55.6%
Buy
2 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
11 analysts · 2026-09-28Mean target $27.55 +201.4%
Now
Current price $9.14
Low$7.00
Mean$27.55
High$56.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SGMT | · | -3.7 | · | · | -42.3% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026